P38 alpha MAP kinase inhibitor inhibits human myeloma cell growth in vivo.

被引：0
|
作者：
Reddy, M [1 ]
Ma, JY [1 ]
Kerr, I [1 ]
Henjarappa, N [1 ]
Navas, T [1 ]
Chakravarty, J [1 ]
Dugar, S [1 ]
Higgins, LS [1 ]
Protter, AA [1 ]
Medicherla, S [1 ]
机构：
[1] Scios Inc, Pharmacol & Cell Biol, Fremont, CA USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.4936.4936
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4936
引用
收藏
页码：315B / 316B
页数：2
相关论文
共 50 条
  • [41] The Third Conformation of p38α MAP Kinase Observed in Phosphorylated p38α and in Solution
    Akella, Radha
    Min, Xiaoshan
    Wu, Qiong
    Gardner, Kevin H.
    Goldsmith, Elizabeth J.
    STRUCTURE, 2010, 18 (12) : 1571 - 1578
  • [42] Inhibition of p38 MAP kinase (MAPK) by BIRB 796 attenuates human neutrophil activation in vivo and inhibits their influx in vivo in a mouse model of peritonitis.
    Schwartz, R
    Kerr, SW
    Harrison, PC
    Madwed, JB
    Pargellis, CA
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S114 - S114
  • [43] Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu.
    Hideshima, T
    Akiyama, M
    Hayashi, T
    Richardson, PG
    Schlossman, RL
    Chauhan, D
    Anderson, KC
    BLOOD, 2002, 100 (11) : 813A - 813A
  • [44] DICAM inhibits angiogenesis via suppression of AKT and p38 MAP kinase signalling
    Han, Seung-Woo
    Jung, Youn-Kwan
    Lee, Eun-Ju
    Park, Hye-Ri
    Kim, Gun-Woo
    Jeong, Jae-Hwan
    Han, Min-Su
    Choi, Je-Yong
    CARDIOVASCULAR RESEARCH, 2013, 98 (01) : 73 - 82
  • [45] Gastrointestinal toxicity as a contributor to hepatotoxicity associated with a p38 alpha kinase inhibitor
    Hamadeh, Hisham
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [46] Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells
    Huang, XK
    Chen, S
    Xu, L
    Liu, YQ
    Deb, DK
    Platanias, LC
    Bergan, RC
    CANCER RESEARCH, 2005, 65 (08) : 3470 - 3478
  • [47] Suppression of ex vivo cytokine production by SB-242235, a selective inhibitor of p38 map kinase.
    Fullerton, T
    Sharma, A
    Prabhakar, U
    Tucci, M
    Boike, S
    Davis, H
    Jorkasky, D
    Williams, W
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 114 - 114
  • [48] SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation
    Casini, Nadia
    Forte, Iris Maria
    Mastrogiovanni, Gianmarco
    Pentimalli, Francesca
    Angelucci, Adriano
    Festuccia, Claudio
    Tomei, Valentina
    Ceccherini, Elisa
    Di Marzo, Domenico
    Schenone, Silvia
    Botta, Maurizio
    Giordano, Antonio
    Indovina, Paola
    ONCOTARGET, 2015, 6 (14) : 12421 - 12435
  • [49] Suppression of p38 activity in vitro and TNFα production in vivo with BIRB 796 bs, a novel p38 kinase inhibitor
    Zimmitti, CS
    Schwartz, R
    Torcellini, CA
    Pargellis, CA
    Madwed, JB
    Weldon, SM
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S114 - S114
  • [50] An essential role of p38α in human cell growth independent of its kinase activity
    Fan, L
    Ye, X
    MOLECULAR BIOLOGY OF THE CELL, 2004, 15 : 367A - 367A
12345